Universal BioProducts mission is to pioneer three-dimensional (3D) cell-based screening assays to safely reduce the time-to-market of new drugs. There is already a clinical need for increased availability of donor tissue for many surgical procedures. Universal BioProducts will leverage innovative tissue engineering platform technologies to develop and commercialize acellular tissue matrices to meet these needs to ultimately benefit the 3D